StockNews.AISignal intelligence
Company intelligence

ORGO

Organogenesis Holdings Inc. · NASDAQ · Healthcare

Price$0.81-16.05% · −$0.15
Market cap105.15MEquity value
P / E27.0Trailing ratio
Volume686.56KLatest session
Market data

ORGO price chart

TradingView
Related signals
1 min delayed

Browse public ORGO signals with their source context and measured market impact. Open any signal for its permanent analysis page.

ORGOSep 26, 2025+5.30% since signal

Why Is Organogenesis Stock Trading Lower Friday?

ReNu failed to achieve primary endpoint in the second Phase 3 trial. Baseline pain reduction slightly improved but lacks statistical significance. Company plans to meet with FDA for BLA pathway discussions. ReNu has a favorable safety profile despite trial outcomes. ORGO shares fell 15.49% to $3.95 following the announcement.

View signal analysis
Research

Company intelligence